Liver Sinusoidal Endothelial Cells Tolerize T Cells across MHC Barriers in Mice 1

Although livers transplanted across MHC barriers in mice are normally accepted without recipient immune suppression, the underlying mechanisms remain to be clarified. To identify the cell type that contributes to induction of such a tolerance state, we established a mixed hepatic constituent cell-lymphocyte reaction (MHLR) assay. Irradiated C57BL/6 (B6) or BALB/c mouse hepatic constituent cells (HCs) and CFSE-labeled B6 splenocytes were cocultured. In allogeneic MHLR, whole HCs did not promote T cell proliferation. When liver sinusoidal endothelial cells (LSECs) were depleted from HC stimulators, allogeneic MHLR resulted in marked proliferation of reactive CD4+ and CD8+ T cells. To test the tolerizing capacity of the LSECs toward alloreactive T cells, B6 splenocytes that had transmigrated through monolayers of B6, BALB/c, or SJL/j LSECs were restimulated with irradiated BALB/c splenocytes. Nonresponsiveness of T cells that had transmigrated through allogeneic BALB/c LSECs and marked proliferation of T cells transmigrated through syngeneic B6 or third-party SJL/j LSECs were observed after the restimulation. Transmigration across the Fas ligand-deficient BALB/c LSECs failed to render CD4+ T cells tolerant. Thus, we demonstrate that Fas ligand expressed on naive LSECs can impart tolerogenic potential upon alloantigen recognition via the direct pathway. This presents a novel relevant mechanism of liver allograft tolerance. In conclusion, LSECs are capable of regulating a polyclonal population of T cells with direct allospecificity, and the Fas/Fas ligand pathway is involved in such LSEC-mediated T cell regulation.

[1]  R. DeMatteo,et al.  Liver Sinusoidal Endothelial Cells Are Insufficient to Activate T Cells , 2004, The Journal of Immunology.

[2]  T. Asahara,et al.  Multiparameter Flow Cytometric Approach for Simultaneous Evaluation of Proliferation and Cytokine‐Secreting Activity in T Cells Responding to Allo‐stimulation , 2004, Immunological investigations.

[3]  P. van Endert,et al.  A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. , 2003, Journal of immunological methods.

[4]  T. Okazaki,et al.  PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver , 2003, The Journal of experimental medicine.

[5]  T. Asahara,et al.  Multiparameter flow cytometric mixed lymphocyte reaction assay using fluorescent cytoplasmic dye for assessing phenotypic property of T cells responding to allogeneic stimulation. , 2003, Transplantation proceedings.

[6]  S. Friedman,et al.  Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. , 2002, Blood.

[7]  K. Sugimachi,et al.  Crucial Fas–Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice , 2002, Immunology.

[8]  T. Kosaka,et al.  Association of CD8+ natural killer T cells in the liver with neonatal tolerance phenomenon. , 2002, Transplantation.

[9]  A. Krasinskas,et al.  Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition , 2002, Nature Medicine.

[10]  D. Adams,et al.  Recruitment of lymphocytes to the human liver , 2002, Immunology and cell biology.

[11]  D. Kreisel,et al.  A simple method for culturing mouse vascular endothelium. , 2001, Journal of immunological methods.

[12]  P. Knolle,et al.  Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. , 2001, Trends in immunology.

[13]  X. Meng,et al.  Adhesion molecule and proinflammatory cytokine gene expression in hepatic sinusoidal endothelial cells following cecal ligation and puncture. , 2001, World journal of gastroenterology.

[14]  S. Rutella,et al.  CD105 (Endoglin) Expression on Hematopoietic Stem/Progenitor Cells , 2001, Leukemia & lymphoma.

[15]  H. Ljunggren,et al.  Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance , 2000, Nature Medicine.

[16]  L. Lu,et al.  Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. , 2000, Transplantation.

[17]  M. Maio,et al.  Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  J. Kalnitsky,et al.  Analysis of apoptosis of lymphoid cells in fish exposed to immunotoxic compounds. , 2000, Cytometry.

[19]  D. Metz,et al.  The liver as a site of T‐cell apoptosis: graveyard, or killing field? , 2000, Immunological reviews.

[20]  A. Thomson,et al.  Effects of Liver-Derived Dendritic Cell Progenitors on Th1- and Th2-Like Cytokine Responses In Vitro and In Vivo1 , 2000, The Journal of Immunology.

[21]  K. Yoshizato,et al.  Heterogeneity of growth potential of adult rat hepatocytes in vitro , 2000, Hepatology.

[22]  A. Juedes,et al.  Selective retention of activated CD8+ T cells by the normal liver. , 1999, Journal of immunology.

[23]  G. Gerken,et al.  Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. , 1999, Gastroenterology.

[24]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[25]  A. Ramaswamy,et al.  Elevated expression of endoglin, a component of the TGF‐β‐receptor complex, correlates with proliferation of tumor endothelial cells , 1999, International journal of cancer.

[26]  D. Nettelbeck,et al.  Cell type specificity of the human endoglin promoter. , 1999, Gene.

[27]  G. Gerken,et al.  Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. , 1999, Journal of immunology.

[28]  J. Desbarats,et al.  Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells , 1998, Nature Medicine.

[29]  D. Häussinger,et al.  Regulation of CD95 (APO‐1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells , 1998, Hepatology.

[30]  H. Gudmundsdottir,et al.  Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. , 1997, The Journal of clinical investigation.

[31]  Wei Li,et al.  Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. , 1997, Journal of immunology.

[32]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.

[33]  J. Pepose,et al.  CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. , 1997, The Journal of clinical investigation.

[34]  M. Krönke,et al.  Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes , 1996, Nature Medicine.

[35]  D. Green,et al.  CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. , 1996, Immunity.

[36]  G. Gerken,et al.  Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. , 1996, Gastroenterology.

[37]  R. Zinkernagel,et al.  Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. , 1996, Journal of immunology.

[38]  M. Westby,et al.  The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. , 1996, Blood.

[39]  A. Gazdar,et al.  Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  R. Calne,et al.  The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats , 1995, Nature Medicine.

[41]  J. Lemasters,et al.  Kupffer cells participate in rejection following liver transplantation in the rat , 1994, Transplant international : official journal of the European Society for Organ Transplantation.

[42]  R. Flavell,et al.  The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. , 1994, Immunity.

[43]  T. Starzl,et al.  Murine liver allograft transplantation: Tolerance and donor cell chimerism , 1994, Hepatology.

[44]  E. Butcher,et al.  Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand. , 1994, Gene.

[45]  T. Starzl,et al.  Cell migration, chimerism, and graft acceptance , 1992, The Lancet.

[46]  P. Lipsky,et al.  Antigen presentation by liver sinusoidal lining cells after antigen exposure in vivo. , 1987, Journal of immunology.

[47]  E. Wisse,et al.  The liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of disse , 1985, Hepatology.

[48]  N. Kamada The immunology of experimental liver transplantation in the rat. , 1985, Immunology.

[49]  F. Zimmermann,et al.  ORTHOTOPIC LIVER ALLOGRAFTS IN THE RAT: THE INFLUENCE OF STRAIN COMBINATION ON THE FATE OF THE GRAFT , 1984, Transplantation.

[50]  B. Roser,et al.  Reversal of transplantation immunity by liver grafting , 1981, Nature.

[51]  R. Binns,et al.  Induction of Immunological Tolerance by Porcine Liver Allografts , 1969, Nature.

[52]  I. N. Crispe,et al.  Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.

[53]  R. Lechler,et al.  The molecular basis of alloreactivity. , 1990, Immunology today.

[54]  P. Seglen Preparation of isolated rat liver cells. , 1976, Methods in cell biology.